{
 "PrintNo":"S3006","Session":2019,"Chamber":"SENATE","BillType":"Senate","Published":"2019-01-31T15:10:40.713336Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2020-01-08","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2019-01-31","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2020-01-08","Chamber":"SENATE"}
 ],
 "Sponsors":[
  {"ID":887,"Name":"Rich Funke","Short":"FUNKE"},{"ID":913,"Name":"Fredrick J. Akshar II","Short":"AKSHAR"},
  {"ID":427,"Name":"Patrick M. Gallivan","Short":"GALLIVAN"},{"ID":423,"Name":"Patty Ritchie","Short":"RITCHIE"},
  {"ID":890,"Name":"Susan Serino","Short":"SERINO"}
 ],
 "Title":"Designates alpha-PVP, its salts, optical isomers and salts of optical isomers, as schedule I stimulant controlled substances",
 "Summary":"Designates alpha-PVP, its salts, optical isomers and salts of optical isomers, as schedule I stimulant controlled substances.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3306, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to designating alpha-PVP as a schedule I stimulant controlled substance",
 "SameAsPrintNo":"A6942-2019","PreviousVersions":["S4743-2015","S816-2017"]
}